| Bioactivity | BVT.13 is an orally active and selective PPARγ agonist with a maximal efficacy similar to that of Rosiglitazone (HY-17386). In addition, BVT.13 exhibits antidiabetic activity in ob/ob mice[1]. |
| CAS | 756813-87-3 |
| Formula | C18H11Cl2N3O4 |
| Molar Mass | 404.20 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ostberg T, et al. A new class of peroxisome proliferator-activated receptor agonists with a novel binding epitope shows antidiabetic effects[J]. Journal of Biological Chemistry, 2004, 279(39): 41124-41130. |